The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Former Glaxo Vice President To Lead C4X Discovery Advisory Network

Mon, 02nd Sep 2019 12:02

(Alliance News) - C4X Discovery Holdings PLC on Monday said it is forming a drug discovery advisory network chaired by "renowned industry veteran" Robin Carr.

Shares in C4X were up 3.8% at 39.95 pence in London at midday.

Carr has held a number of senior roles, including at GlaxoSmithKline PLC, where he was he was senior vice president of Drug Design & Selection.

The advisory network is intended to bring experts in the field of drug discovery and development to the company to enhance its capabilities, and to act as company ambassadors within the industry.

C4X Chief Executive Clive Dix said: "We are delighted to announce the formation of our advisory network and to be working closely with prestigious world leading experts in drug discovery. As part of our strategy to become the world's most productive drug discovery company, we are continually enhancing both our network and expertise. As international thought leaders, the advisory network's deep industry expertise will enable us to accelerate progress of our portfolio and we are particularly proud that Robin will be chair. Under Robin's guidance, we believe the advisory network will advance our vision and reputation within the industry."

More News
7 May 2020 17:57

C4X Discovery Raises GBP1.6 Million Via Share Placing

C4X Discovery Raises GBP1.6 Million Via Share Placing

Read more
24 Jan 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jan 2020 10:40

C4X Discovery Annual Loss Widens, Confident In Strategy

C4X Discovery Annual Loss Widens, Confident In Strategy

Read more
7 Jan 2020 09:59

C4X losses widen as its revenue drops to nil

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced a fall in revenue to nil in its full-year results on Tuesday, from £7.06m in 2018, which the board said as driven entirely by the Indivior licensing agreement in that year.

Read more
31 Dec 2019 10:47

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Oct 2019 17:06

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

Read more
24 Oct 2019 11:09

C4X Discovery Raises Over GBP5 Million In Discounted Placing

C4X Discovery Raises Over GBP5 Million In Discounted Placing

Read more
24 Oct 2019 10:31

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Read more
1 Oct 2019 10:15

C4X makes solid progress across portfolio of programmes

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced progress across a number of key programmes in line with its strategy on Tuesday, reporting that it was continuing to progress its strategy to deliver programmes for out-licensing its NRF-2 activator, IL-17 inhibitor and LifeArc collaboration.

Read more
27 Sep 2019 15:39

C4X upbeat as its molecule progresses with Indivior

(Sharecast News) - Drug discovery company C4X Discovery Holdings noted an announcement on Friday that the National Institutes of Health (NIH) in the United States has granted Indivior's application titled "Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder'.

Read more
30 Apr 2019 12:59

C4X Discovery Interim Loss Widens, Focuses On Inking Deals

LONDON (Alliance News) - C4X Discovery Holdings PLC said on Tuesday it had a "strong" first half, though its loss widened on higher research and development costs.The drug firm to

Read more
23 Apr 2019 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 24 April PetropavolskFull Year ResultsBoohoo GroupFull Year HealthFull

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.